Bruker Daltonics Launches RAID-AFM and RAID-S2 for Long-Term Chemical Monitoring in Homeland Security and Defense Infrastructure Protection.

TAMPERE, Finland -- The NBC Detection Business of Bruker Daltonik GmbH, based in Leipzig, Germany, today announces the RAID(TM)-AFM and the RAID(TM)-S2, two new stationary chemical detectors, at the NBC 2006 Symposium on Chemical, Biological, Nuclear and Radiological Threats in Tampere, Finland.

For over 15 years, Bruker Daltonics has been recognized as a leading expert in chemical detection applications of ion mobility spectrometry (IMS). The Company has implemented its advanced and unique IMS technology in its RAID(TM) series of mobile and stationary chemical agent and toxic industrial chemical detectors, which have earned a sterling reputation. The latest version of the Company's IMS spectrometer is the handheld RAID-M 100, which has been called the "world-leader" in the NBC detection community, based on its superior interference rejection, ease-of-use and logistical benefits. The RAID-M has been included in the U.S. Approved Product List for Homeland Security according to "The Support Anti-Terrorism by Fostering Effective Technologies Act of 2002 (SAFETY ACT)". The new RAID-M 100 technology has now been integrated into the Company's stationary platform, formerly known as RAID-S.

Originally designed to serve both the chemical defense and the critical infrastructure market, the RAID-S has now been redesigned and updated, resulting in two different products for two different applications. The new RAID-AFM (Advanced Facility Monitor) meets the demand for a "slimmed down" instrument for critical infrastructure and facilities monitoring, while the RAID-S2 is a hardened instrument available for military missions.

Both new products provide numerous benefits and further improvements, including even better detection performance, improved long-term storage, lower maintenance requirements, an intuitive library concept, and a lower activity isotope source. In addition, the new RAID-AFM provides web-based diagnostics and control capabilities.

Mr. Sebastian Meyer-Plath, Vice President for NBC Detection at Bruker Daltonics, commented: "With the launch of these two new products, we are addressing the emerging differentiated market requirements for stationary homeland security chemical agent and toxic industrial chemical monitoring and detection for critical infrastructure and facilities, as well as for integrated CWA detection in mobile military platforms, such as navy ships."

ABOUT BRUKER BIOSCIENCES (NASDAQ: BRKR)

Bruker BioSciences Corporation, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker Daltonics Inc. and Bruker AXS Inc. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. Bruker Daltonics also offers a broad line of nuclear, biological and chemical (NBC) detection products for defense and homeland security. Bruker AXS is a leading developer and provider of life science, materials research and industrial X-ray analysis tools. For more information about Bruker BioSciences Corporation, please visit www.bruker-biosciences.com

CAUTIONARY STATEMENT

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the companies' reorganization strategies, integration risks, failure of conditions, technological approaches, product development, market acceptance, cost and pricing of the companies' products, changes in governmental regulations, capital spending and government funding policies, FDA and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our respective annual reports on Form 10-K, our most recent quarterly reports on Form 10-Q, and our current reports on Form 8-K. We disclaim any intent or obligation to update these forward-looking statements.